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Reframing the Opioid Epidemic
as a National Emergency
On August 10, 2017, President Trump announced his
intention to declare a national emergency following
the recommendation of the President’s Commission
on Combating Drug Addiction and the Opioid Crisis.1
Opioidabuse is among themost consequential prevent-
able public health threats facing the nation. More than
600000deaths have occurred to date, with 180000
more predicted by 2020.2 Of the 20.5 million US resi-
dents 12 years or older with substance use disorders in
2015, 2 million were addicted to prescription pain
relievers.3Adeclarationof anational emergencyautho-
rizes public health powers,mobilizes resources, and fa-
cilitates innovative strategies to curb a rapidly escalat-
ing public health crisis.
TheOpioid Crisis
Approximately one-third of individuals in the United
States report experiencing chronic pain, and many re-
ceive prescription opioids such as oxycodone and acet-
aminophen/hydrocodone.Opioids are among themost
heavilyprescribedpharmaceuticals, and theyarehighly
addictive. Eightypercent of newheroin users havepre-
viously misused prescription painkillers.
Although effective pain relief is a vital component
of modern health care, the public health effects of opi-
oid addiction have escalated sharply. Opioid overdose
deaths increased 156% from 21 088 in 2010 to 33091
in 2015, resulting in decreased life expectancy among
users.4 Overdose deaths among teenagers increased
19%from649 in2014 to772 in2015—more thandouble
the rate since 1999.5 Highly potent, chemically manu-
factured opioids (eg, car- and furanyl-fentanyl)—
available illegally or bymail order—arepotentially lethal
through unintentional skin absorption, inhalation, in-
correct dosing, or lacing with other drugs.6
Sharing drug injection equipment can transmit
blood-borne infections such as human immunodefi-
ciency virus (HIV) or hepatitis B or C. If current rates of
infection continue, the US Centers for Disease Control
andPrevention (CDC)estimates that 1 in 23womenand
1 in 36menwho inject drugswill be diagnosedwithHIV
during their lifetime.7Opioidusealsohascontributed to
an estimated tripling of hepatitis C infections between
2010and2015.Thecombinedeconomic influenceof the
opioid epidemic (health care, labor, and criminal justice
costs) was estimated at $92 billion in 2016 (an increase
of67%overadecadeago).8Enhancedpublichealthpre-
ventionnationallynotonlywouldreducedeathandmor-
bidity, but would likely also be highly cost-effective.
Expanding Conceptions of Public Health
Emergencies
Modernpublic health emergencydeclarations typically
focus on rapidly spreading infectious diseases such as
West Nile virus (2002), severe acute respiratory syn-
drome (2003), H1N1 influenza (2009), Ebola virus
(2014), andZika virus (2016). They are also understood
to includebiosecurity threats such as anthrax (2001) or
smallpox. Humanitarian disasters in the United States,
such as hurricanes Katrina (2005) and Sandy (2012),
have also triggered public health emergency declara-
tions, particularly at the state level.
This traditional model of public health emergen-
cies, however, is beginning to change. In the past
decade states and localities have declared emergencies
for health crises such as seasonal influ-
enza, lead-contaminated drinking
water, and asbestos releases—even
domestic violence, food insecurity, and
homelessness. As early as 2011, 6 states
(Alaska, Arizona, Florida, Massachu-
setts, Maryland, and Virginia) and sev-
eral tribal governments (eg, Red Lake
Nation, Mashpee Wampanoag Tribe,
Leech Lake, Band of Chippewa Indians, White Earth
Nation) have already declared public health emergen-
cies in response to the opioid epidemic.
Existing public health strategies aremeaningful and
necessary,butanemergencydeclarationcouldbeaturn-
ing point for a national surge response. Current re-
sponse efforts include patient and prescriber surveil-
lance, reduced medical prescribing, and counseling or
treatment forpersonsat riskoralreadyaddicted.TheUS
Food and Drug Administration (FDA) and National Insti-
tutesofHealthurgeresearchanddevelopmentof lessad-
dictivepainkillers,whileCDCcallsforgreaterphysicianand
pharmacist education to avoid inappropriate prescrib-
ing.USCustomsandBorderProtectionagents arework-
ing to restrict the flowof illicitopioids,while lawenforce-
ment is targeting illicit drug dealers and unethical
physicians. Emergency medical technicians and family
members are administering life-saving naloxone with
fewer liabilityconcernsduetostateGoodSamaritan laws.
Essential Powers and Resources
An emergency declaration mobilizes powers and re-
sources that are either currently unavailable ormired in
A declaration of a national emergency
authorizes public health powers,
mobilizes resources, and facilitates
innovative strategies to curb a rapidly
escalating public health crisis.
VIEWPOINT
LawrenceO.Gostin,
JD
O’Neill Institute for
National and Global
Health Law,
Georgetown University
Law Center,
Washington, DC.
JamesG.Hodge Jr, JD,
LLM
Center for Public
Health Law and Policy,
Sandra Day O’Connor
College of Law, Arizona
State University,
Phoenix.
SarahA.Noe, BA
University of
Pennsylvania Law
School, Philadelphia.
Corresponding
Author: Lawrence O.
Gostin, JD,
Georgetown University
Law Center, 600
New Jersey Ave, NW,
McDonough 568,
Washington, DC 20001
(gostin@law
.georgetown.edu).
Opinion
jama.com (Reprinted) JAMA Published online August 23, 2017 E1
© 2017 American Medical Association. All rights reserved.
Downloaded From: http://jamanetwork.com/ by a Georgetown University Medical Center User  on 09/27/2017
legal obstacles. ThePresident’sCommission recommends legal and
policy reforms including the following:betterMedicaid coverage for
substance use treatment; expanded funding for integrated medi-
cation-assistedtreatments;medical training inappropriatepainman-
agement; andwaiversofhealth informationprivacy regulations that
impede access to complete data on fraudulent prescription prac-
tices and those whomisuse opioids.
Coordination of public and private strategies would be facili-
tated by a crisis standard of care supported by substantial funding
through federal laws such as the Comprehensive Addiction and
Recovery Act and 21st Century Cures Act. Expansion of health in-
surance coverage via temporary waivers of key provisions of the
Affordable Care Act would open greater access to addiction ser-
vices.Apublichealthemergencydeclarationcouldalso increasede-
ployment and use of appointed federal or state officials or volun-
teer health practitioners, especially in resource-strapped rural
communities where opioid-related deaths per capita often exceed
those in urban areas.
Jails and prisons are another focal point for public health inter-
ventions. Significant numbers of prisoners either used opioids in
committing their crimes or were incarcerated with an opioid-
related use disorder. Effective interventions would provide ex-
pandedtreatment toaddictedprisonersbyoverridingMedicaidpro-
visions that terminatebenefits for incarceratedpopulations.Greater
use of drug courts that divert opioid users from punitive to thera-
peutic settings is also essential.
Emergency waivers of federal drug possession or other legal
barriers would enable implementation of clean injection equip-
ment programs or facilities, which are under consideration in
New York City, Seattle-King County in Washington, and else-
where. Federal emergency determinations allow FDA to issue
emergency use authorizations for unapproved medical products
(or different uses of approved products), while hastening efforts
to remove dangerous prescription opioids from the market. The
Public Readiness and Emergency Preparedness Act, triggered
only by a declaration, provides limited immunity to health profes-
sionals and pharmaceutical companies distributing or implement-
ing federally approved medical countermeasures, while authoriz-
ing federal compensation for injuries.
AWell-Targeted Emergency Declaration of Limited Duration
Declaring a national emergency in response to a decades-long, es-
calating public health crisis raises valid concerns. Principal among
these is thepotential formorepunitive responses focusedon incar-
ceration. There is also the concern that an emergency declaration
could justify paternalistic interventions that deny rights to affected
patients or their caregivers.
Deploying surge powers and resources in response to the opi-
oidepidemic coulddivert attention fromothermajornational prob-
lems such as cancer, diabetes, and cardiovascular disease. It could
also set a precedent for framingnearly anymajor health hazard as a
public health emergencyeven though suchdeclarationswereorigi-
nally conceived as temporary responses to fast-moving epidemics,
bioterrorism, or humanitarian disasters.
Still, a federal emergency declaration is warranted by the ad-
dictive quality of opioids, substantial increases in opioid abuse and
related deaths, potential for continued catastrophic losses of life,
and epidemic-like spread of needle-borne infections through so-
cialnetworks. Itmayhavetakenyears for thisepidemic to reachcrisis
levels, but it could take onlymonths for coordinated, bipartisan in-
terventions across public andprivate sectors to takehold. Prevent-
able deaths and injuries attributable to opioidmisuse will never be
acceptable, but the emergency should come to an end when opi-
oid addiction and death rates return to historic lower levels.
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